Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction
Authors
Ntentas, G.Darby, S. C.
Aznar, Marianne Camille
Hodgson, D. C.
Howell, R. M.
Maraldo, M. V.
Ahmed, S.
Ng, A.
Aleman, B. M. P.
Cutter, D. J.
Affiliation
Nuffield Department of Population Health, University of Oxford, Oxford, UK; Guy's and St Thomas' NHS Foundation Trust, Department of Medical Physics, London, UKIssue Date
2020
Metadata
Show full item recordAbstract
Background and purpose: Radiation-related heart disease (RRHD) can occur many decades after thoracic radiotherapy for Hodgkin lymphoma (HL) or childhood cancer (CC). To quantify the likely risk of RRHD for patients treated today, dose-response relationships derived from patients treated in previous decades are used. Publications presenting these dose-response relationships usually include estimates of uncertainties in the risks but ignore the effect of uncertainties in the reconstructed cardiac doses. Materials/methods: We assessed the systematic and random uncertainties in the reconstructed doses for published dose-response relationships for RRHD risk in survivors of HL or CC. Using the same reconstruction methods as were used in the original publications, we reconstructed mean heart doses and, wherever possible, mean left-ventricular doses for an independent case-series of test patients. These patients had known, CT-based, cardiac doses which were compared with the reconstructed doses to estimate the magnitude of the uncertainties and their effect on the dose-response relationships. Results: For all five reconstruction methods the relationship between reconstructed and CT-based doses was linear. For all but the simplest reconstruction method, the dose uncertainties were moderate, the effect of the systematic uncertainty on the dose-response relationships was less than 10%, and the effects of random uncertainty were small except at the highest doses. Conclusions: These results increase confidence in the published dose-response relationships for the risk of RRHD in HL and CC survivors. This may encourage doctors to use these dose-response relationships when estimating individualised risks for patients-an important aspect of personalising radiotherapy treatments today.Citation
Ntentas G, Darby SC, Aznar MC, Hodgson DC, Howell RM, Maraldo MV, et al. Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction. Radiother Oncol. 2020.Journal
Radiotherapy and OncologyDOI
10.1016/j.radonc.2020.08.022PubMed ID
32890611Additional Links
https://dx.doi.org/10.1016/j.radonc.2020.08.022Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.radonc.2020.08.022
Scopus Count
Collections
Related articles
- Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
- Authors: Bates JE, Shrestha S, Liu Q, Smith SA, Mulrooney DA, Leisenring W, Gibson T, Robison LL, Chow EJ, Oeffinger KC, Armstrong GT, Constine LS, Hoppe BS, Lee C, Yasui Y, Howell RM
- Issue date: 2023 Aug 1
- Cardiac Structure Doses in Women Irradiated for Breast Cancer in the Past and Their Use in Epidemiological Studies.
- Authors: Duane FK, McGale P, Brønnum D, Cutter DJ, Darby SC, Ewertz M, Hackett S, Hall P, Lorenzen EL, Rahimi K, Wang Z, Warren S, Taylor CW
- Issue date: 2019 May
- Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation X-rays.
- Authors: van Nimwegen FA, Cutter DJ, Schaapveld M, Rutten A, Kooijman K, Krol AD, Janus CP, Darby SC, van Leeuwen FE, Aleman BM
- Issue date: 2015 May 1
- Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study.
- Authors: Shrestha S, Bates JE, Liu Q, Smith SA, Oeffinger KC, Chow EJ, Gupta AC, Owens CA, Constine LS, Hoppe BS, Leisenring WM, Qiao Y, Weathers RE, Court LE, Pinnix CC, Kry SF, Mulrooney DA, Armstrong GT, Yasui Y, Howell RM
- Issue date: 2021 Oct
- Risk of valvular heart disease after treatment for Hodgkin lymphoma.
- Authors: Cutter DJ, Schaapveld M, Darby SC, Hauptmann M, van Nimwegen FA, Krol AD, Janus CP, van Leeuwen FE, Aleman BM
- Issue date: 2015 Apr